Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Probiotics in Asthma and Allergy Prevention
Maurizio Mennini1, Lamia Dahdah1, Maria Cristina Artesani1
1Division of Allergy, Bambino Gesù Children's Hospital, Vatican City, Vatican City.
Insights
Probiotics show potential for infant health, but research on their use for preventing food allergies is limited. More evidence is needed before specific recommendations can be made for probiotics in allergy prevention.
Area of Science:
- Microbiology
- Immunology
- Pediatrics
Background:
- Interest in probiotics for infant health is growing, with research linking infant microbiome alterations to health outcomes.
- A healthy gut microbiota is crucial for developing immune tolerance, and probiotics may offer protection against diseases.
- Analyzing gut dysbiosis in food allergy is complex due to varied study designs and methodologies.
Purpose of the Study:
- To review the current evidence on probiotics and their role in infant health, particularly concerning food allergy.
- To highlight the challenges in studying probiotics' effects on the infant gut microbiome and immune development.
- To assess the existing recommendations for probiotic use in allergy prevention and treatment.
Main Methods:
- Literature review of studies on probiotics, infant microbiome, and immune tolerance.
- Analysis of interventional studies investigating probiotic effects on disease development.
- Evaluation of factors complicating dysbiosis analysis in food allergy subjects.
Main Results:
- While in vitro evidence for probiotics is valid, clinical data supporting their use in allergy and asthma prevention is insufficient.
- Current scientific societies do not recommend pre- or probiotics for treating food allergies, with prevention use based on limited evidence.
- Significant heterogeneity exists across studies, hindering direct comparisons and definitive conclusions.
Conclusions:
- There is insufficient evidence to recommend specific probiotics for preventing allergy and asthma in infants.
- Further high-quality research is required to establish the efficacy and safety of probiotics in this context.
- Current recommendations for probiotic use in allergy prevention are based on limited scientific backing.
Abstract:
Interest in probiotic research and its potential benefits in infant foods are relatively recent but significantly increasing. The evolution of the knowledge in the last 20 years demonstrated that alterations in the microbiome may be a consequence of events occurring during infancy or childhood, including prematurity, cesarean section, and nosocomial infections. Several pieces of evidence prove that a "healthy" intestinal microbiota facilitates the development of immune tolerance. Interventional studies suggest that probiotics could be protective against the development of many diseases. Nevertheless, many factors complicate the analysis of dysbiosis in subjects with food allergy. Comparison in-between studies are difficult, because of considerable heterogeneity in study design, sample size, age at fecal collection, methods of analysis of gut microbiome, and geographic location. Currently, there is no positive recommendation from scientific societies to use pre- or probiotics for treatment of food allergy or other allergic manifestations, while their use in prevention is being custom-cleared. However, the recommendation is still based on little evidence. Although there is valid scientific evidence in vitro, there is no sufficient information to suggest the use of specific probiotics in allergy and asthma prevention.
Related Concept Videos
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

